Table 3.
S. no | Compounds | Solubility (Log S) | TPSA (Å) | Druglikeness | Drug score | Mutagenic | Tumorigenic | Reproductive effect | Irritants |
---|---|---|---|---|---|---|---|---|---|
1 | 3-O-β-D-Glucopyranoside (3-glucogallic acid) | −0.63 | 177.1 | −3.44 | 0.48 | No | No | No | No |
2 | 3-O-(6-Galloylglucoside) | −1.32 | 243.9 | 1.77 | 0.71 | No | No | No | No |
3 | 3-O-Dodecanoyl (3-lauroylgallic acid) | − 4.04 | 104.0 | −25.23 | 0.3 | No | No | No | No |
4 | 3-O-Methyl gallic acid | −1.06 | 86.99 | 1.1 | 0.85 | No | No | No | No |
5 | 4-O-(6-Galloylglucoside) | −1.32 | 243.9 | 1.99 | 0.72 | No | No | No | No |
6 | 4-O-Methyl gallic acid | −1.05 | 86.99 | 1.24 | 0.69 | No | Medium risk | No | No |
7 | Epicatechin gallate | −2.16 | 197.3 | 1.58 | 0.7 | No | No | No | No |
8 | Epicatechin | −1.76 | 110.3 | 1.92 | 0.87 | No | No | No | No |
9 | Epigallocatechin gallate | −2.16 | 197.3 | 1.58 | 0.7 | No | No | No | No |
10 | Epigallocatechin | −1.47 | 130.60 | 1.10 | 0.82 | No | No | No | No |
11 | Gallic acid | −0.74 | 97.99 | 0.12 | 0.27 | Yes | No | Yes | No |
12 | Lauryl gallate | −3.87 | 86.99 | −20.89 | 0.28 | No | No | No | No |
13 | Octyl gallate | −2.79 | 86.99 | −20.89 | 0.25 | No | No | No | Yes |
14 | Propyl gallate | −1.44 | 86.99 | 0.54 | 0.17 | Yes | Yes | Yes | No |
15 | Pyrogallol | −0.73 | 60.69 | −3.5 | 0.07 | Yes | Yes | Yes | Yes |
16 | Resorcinol | −1.02 | 40.46 | − 1.94 | 0.12 | Yes | Yes | No | Yes |
Control drugs | |||||||||
17 | Dexamethasone | −3.25 | 94.83 | 3.18 | 0.8 | No | No | No | No |
18 | Hydroxychloroquine | −3.55 | 48.39 | 6.54 | 0.48 | Yes | No | No | No |
19 | Remdesivir | −4.99 | 213.30 | −30.39 | 0.05 | No | Yes | Yes | Yes |
Solubility, ranging 0 (highly soluble) to −6 (poorly soluble); TPSA, topological polar surface area ≤ 130 Å2; druglikeness, scores with positive value are likely to be an oral drug; drug score, 0-1.0